Bristol Myers Squibb
name
Bristol Myers Squibb
id
BMY
summary
Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. It is one of the world's largest pharmaceutical companies, consistently ranking on the Fortune 500 list. BMS manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis, and psychiatric disorders. The company's primary R&D sites are in the United States and Europe, with additional facilities worldwide. BMS has a history of mergers and acquisitions, including the notable acquisition of Celgene in 2019 for $74 billion, making it the largest pharmaceutical-company acquisition ever at the time.
industry
Pharmaceuticals
founded
1887
founders
William McLaren Bristol, John Ripley Myers
headquarters
Princeton, New Jersey, U.S.
area_served
Worldwide
key_people
Giovanni Caforio (chairman), Chris Boerner (CEO), David Elkins (CFO)
revenue
US$45.01 billion (2023)
operating_income
US$8.44 billion (2023)
net_income
US$8.04 billion (2023)
total_assets
US$95.16 billion (2023)
total_equity
US$29.43 billion (2023)
number_of_employees
34,100 (2023)
website
bms.com